Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.03 USD | +0.86% | -7.09% | +72.57% |
Chart calendar Iovance Biotherapeutics, Inc.
Upcoming events on Iovance Biotherapeutics, Inc.
Past events on Iovance Biotherapeutics, Inc.
2024-03-12 10:45 am | Barclays Global Healthcare Conference |
2024-03-04 11:10 am | TD Cowen Health Care Conference |
2024-02-28 04:30 pm | Q4 2023 Earnings Call |
2024-02-28 04:01 pm | Q4 2023 Earnings Release |
2024-02-16 04:15 pm | AMTAGVI™ FDA Approval Call |
2023-11-07 04:30 pm | Q3 2023 Earnings Call |
2023-11-07 04:01 pm | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Long-term Efficacy and Safety of Lifileucel Tumor |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Study of Lifileucel Tumor Infiltrating Lymphocyte |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting |
2023-10-21 09:15 am | European Society for Medical Oncology Congress |
2023-09-11 11:15 pm | International Association for the Study of Lung Cancer World Conference - Adam J. Schoenfeld |
2023-09-11 06:00 am | International Association for the Study of Lung Cancer World Conference - Dean Fennell |
2023-09-07 12:45 pm | Wells Fargo Healthcare Conference |
2023-08-08 04:30 pm | Q2 2023 Earnings Call |
2023-08-08 04:01 pm | Q2 2023 Earnings Release |
2023-06-26 05:00 pm | Investor Meeting - Key Opinion Leaders |
2023-06-09 11:00 am | Jefferies Global Healthcare Conference |
2023-06-06 11:00 am | Annual General Meeting |
2023-06-03 02:15 pm | American Society of Clinical Oncology Conference - Abstract No:TPS9607 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,19 2,12 -44.03% | 161 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -261 -256 -1.87% | -340 -330 -2.8% | -390 -389 -0.09% | -449 -420 -6.87% | -302 |
EBIT Million USD | Released Forecast Spread | -207 -196 -5.73% | -262 -260 -0.63% | -343 -331 -3.63% | -399 -395 -0.91% | -461 -451 -2.01% | -359 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -198 -187 -5.92% | -260 -257 -0.88% | -342 -330 -3.78% | -396 -394 -0.52% | -448 -440 -1.63% | -352 |
Net income Million USD | Released Forecast Spread | -198 -187 -5.92% | -260 -257 -0.92% | -342 -330 -3.78% | -396 -394 -0.52% | -444 -439 -1.17% | -352 |
EPS USD | Released Forecast Spread | -1,59 -1,50 -6.14% | -1,88 -1,85 -1.9% | -2,23 -2,15 -3.63% | -2,49 -2,49 -0.15% | -1,89 -1,88 -0.8% | -1,30 |
Announcement Date | 25/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,24 5,38 -95.57% | 0,47 4,89 -90.4% | 0,48 1,40 -65.55% | 2,09 | 30,5 | 60,6 | 77,3 | 119 |
EBITDA Million USD | Released Forecast Spread | -98,1 -88,2 -11.25% | -89,9 -100 10.26% | -97,5 -101 3.19% | -97,9 -106 7.78% | -104 -105 1.12% | -108 -110 1.56% | -107 | -128 | -129 | -128 | -132 | |||
EBIT Million USD | Released Forecast Spread | -99,5 -87,4 -13.83% | -91,7 -100 8.67% | -99,7 -96,0 -3.87% | -100 -102 1.28% | -107 -103 -3.46% | -111 -111 0.11% | -110 -172 36.16% | -118 -109 -8.53% | -121 -112 -8.09% | -111 | -97,7 | -76,0 | -67,0 | -43,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -99,3 -86,8 -14.45% | -91,6 -100 8.5% | -99,3 -95,9 -3.55% | -99,6 -100 0.76% | -105 -103 -2.07% | -107 -131 17.98% | -107 -171 37.27% | -115 -107 -7.19% | -118 -111 -6.41% | -113 | -98,2 | -78,4 | -73,1 | -40,8 |
Net income Million USD | Released Forecast Spread | -99,3 -86,8 -14.45% | -91,6 -100 8.5% | -99,3 -95,9 -3.55% | -99,6 -100 0.49% | -105 -103 -2.07% | -107 -131 17.98% | -107 -171 37.55% | -114 -107 -6.04% | -116 -111 -4.97% | -113 | -98,2 | -78,5 | -73,1 | -40,8 |
EPS USD | Released Forecast Spread | -0,63 -0,56 -13.05% | -0,58 -0,64 9.38% | -0,63 -0,61 -4.05% | -0,63 -0,64 1.14% | -0,64 -0,64 -0.43% | -0,50 -0,75 33.42% | -0,47 -0,85 44.79% | -0,46 -0,45 -1.77% | -0,45 -0,44 -2.51% | -0,43 | -0,36 | -0,29 | -0,27 | -0,06 |
Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 07/11/23 | 28/02/24 | - | - | - | - | - |
Past sector events for Iovance Biotherapeutics, Inc.
2024-02-28 04:05 pm | CAREDX, INC: Q4 2023 Earnings Release |
2024-02-28 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-02-22 04:05 pm | VERACYTE, INC.: Q4 2023 Earnings Release |
2024-02-22 04:05 pm | GUARDANT HEALTH, INC.: Q4 2023 Earnings Release |
2024-02-22 04:05 pm | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Earnings Release |
2024-02-21 04:05 pm | EXACT SCIENCES CORPORATION: Q4 2023 Earnings Release |
2024-02-15 | SEEGENE, INC.: Q4 2023 Earnings Release |
2023-11-09 | SEEGENE, INC.: Q3 2023 Earnings Release |
2023-11-09 04:05 pm | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q3 2023 Earnings Release |
2023-11-08 04:05 pm | CAREDX, INC: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Iovance Biotherapeutics, Inc. - Nasdaq
- Calendar Iovance Biotherapeutics, Inc.